Goteborg: A Mumbai-born Indian doctor Suchitra Holgersson made a landmark breakthrough in medical science, as the first biologically tissue-engineered vein grown from a patient's own stem cells has been successfully transplanted into a 10-year-old girl with portal vein obstruction, dramatically enhancing her quality of life, reports The Lancet.
The report says, a team of doctors, funded by the Swedish government, grew veins in test tubes and successfully transplanted them in a Swedish child.
The report says, "a 10 year old girl with extrahepatic portal vein obstruction was admitted to the Sahlgrenska University Hospital in Gothenburg, Sweden, for a bypass procedure between the superior mesenteric vein and the intrahepatic left portal vein. A 9 cm segment of allogeneic donor iliac vein was decellularised and subsequently recellularised with endothelial and smooth muscle cells differentiated from stem cells obtained from the bone marrow of the recipient. This graft was used because the patient's umbilical vein was not suitable and other strategies, like liver transplantation, require lifelong immunosuppression."
The results could offer hope of growing human cells in laboratory and a potential new way for patients lacking healthy veins to undergo dialysis or heart bypass surgery without the problems of synthetic grafts (that are prone to clots and blockages) or the need for lifelong immunosuppressive drugs.
The report says, a team of doctors, funded by the Swedish government, grew veins in test tubes and successfully transplanted them in a Swedish child.
The report says, "a 10 year old girl with extrahepatic portal vein obstruction was admitted to the Sahlgrenska University Hospital in Gothenburg, Sweden, for a bypass procedure between the superior mesenteric vein and the intrahepatic left portal vein. A 9 cm segment of allogeneic donor iliac vein was decellularised and subsequently recellularised with endothelial and smooth muscle cells differentiated from stem cells obtained from the bone marrow of the recipient. This graft was used because the patient's umbilical vein was not suitable and other strategies, like liver transplantation, require lifelong immunosuppression."
Advertisement
COMMENTS
Advertisement
Men's Eggs, Women's Sperm: Stem Cell Science May Change How We Reproduce Delhi Court Allows Stem Cell Therapy For 2 Children Suffering From Autism Scientists Develop First Synthetic Human Embryos Using Stem Cells Life On Earth Originates From One Ancestor, Older Than Previously Believed Send Reports Every 2 Hours: Centre To States On Kolkata Horror Protests For Debate Against Kamala Harris, Donald Trump Picks This Hindu American Gaza Records First Polio Case In 25 Years As UN Urges Vaccinations Safety "Deteriorating" At Ukraine Nuclear Plant After Strike: UN Watchdog Trump, Kamala Harris To Fight For Pennsylvania Votes With Rally, Bus Tour Track Latest News Live on NDTV.com and get news updates from India and around the world.